10x Genomics, Inc.
- Stock
- Ticker TXG
- ISIN US88025U1097
- Nasdaq
Performance, volatility and drawdowns of 10x Genomics, Inc. since 09/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $3,212. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −96.5% in 04/2025, measured from the peak in 04/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 165 | 155 | 173 | 149 | 166 | 151 | 151 | 151 |
| Gross profit | 111 | 105 | 125 | 100 | 113 | 106 | 112 | 113 |
| Operating income | -50 | -39 | 30 | -32 | -20 | -17 | -20 | -16 |
| EBITDA | -41 | -31 | 38 | -22 | -9.5 | -7.1 | -9.9 | -6.6 |
| Net income | -49 | -34 | 35 | -27 | -16 | -13 | -18 | -19 |
| Earnings per share | -0.41 | -0.28 | 0.28 | -0.22 | -0.13 | -0.10 | -0.14 | -0.15 |
| Balance sheet | ||||||||
| Total assets | 919 | 903 | 980 | 1,027 | 1,041 | 1,016 | 1,030 | 1,063 |
| Liabilities | 209 | 196 | 207 | 242 | 245 | 201 | 205 | 225 |
| Equity | 710 | 707 | 773 | 785 | 796 | 814 | 826 | 838 |
| Cash | 344 | 377 | 398 | 433 | 474 | 490 | 503 | 526 |
| Cash flow | ||||||||
| Operating cash flow | -6.7 | 34 | 18 | 43 | 41 | 26 | 17 | 16 |
| Capital expenditure | -2.7 | -1.9 | -1.6 | -0.7 | -1.8 | -1.6 | -1.6 | -1.0 |
| Free cash flow | -9.5 | 32 | 16 | 43 | 39 | 25 | 15 | 15 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +85.7%, weakest 2022 at −75.5%. 4 of 6 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 6 Nov 2026 | −$0.15 |
| 7 Aug 2026 | −$0.14 |
| 8 May 2026 | −$0.10 |
| 13 Feb 2026 | −$0.13 |
| 7 Nov 2025 | −$0.22 |
| 8 Aug 2025 | $0.28 |
| 9 May 2025 | −$0.28 |
| 13 Feb 2025 | −$0.41 |
| 29 Oct 2024 | −$0.30 |
| 8 Aug 2024 | −$0.32 |
| 30 Apr 2024 | −$0.50 |
| 15 Feb 2024 | −$0.41 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €6.1bn
- Market cap in trading currency
- $6.78bn
- Enterprise value
- $6.20bn
- P/E
- –
- P/S
- 10.95
- P/B
- 8.09
- EV/Sales
- 10.02
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- 1.4%
Results (last four quarters)
- Revenue
- $619m
- Gross profit
- $445m
- EBITDA
- −$33.0m
- Net income
- −$67.1m
- Earnings per share
- −$0.52
- Revenue per share
- $4.73
- Revenue growth
- +1.1%
- Earnings growth
- –
Profitability
- Gross margin
- 71.9%
- Operating margin
- -11.7%
- Net margin
- -10.8%
- Return on equity
- -8.3%
- Return on assets
- -6.3%
Balance sheet and cash flow
- Cash
- $576m
- Cash per share
- $4.40
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 5.12
- Book value per share
- $6.41
- Operating cash flow
- $99.7m
- Free cash flow
- $93.8m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 131m
- Volume
- 3.23m
- Avg. volume 3 months
- 3.39m
- Relative volume
- 1.0
Price and technicals
- Price
- $51.80
- 1 day
- −9.7%
- 52-week high
- $97.74
- 52-week low
- $15.46
- Distance to 52-week high
- −47.0%
- Distance to 52-week low
- +235.1%
- Distance to 50-day line
- −28.9%
- Distance to 200-day line
- +19.1%
- RSI (14)
- 35
- Volatility 1M
- 112.7%
Performance
- 1 week
- −11.0%
- 1 month
- −25.7%
- 3 months
- −18.8%
- 6 months
- +118.8%
- YTD
- +217.6%
- 1 year
- +231.0%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has TXG performed since 09/2019?
$10,000 grew to $9,820 by 20 Nov 2026, which is −0.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is TXG?
Volatility was 64.2% per year, measured on monthly returns. The largest decline from a peak was −96.5%, with the low in 04/2025.
How does TXG compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 16.4% volatility, TXG returned −0.3% at 64.2%. The correlation of monthly returns was 0.53; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.